A time-resolved fluorescence immunoassay for the determination of a novel respiratory therapeutic agent, AR-C68397XX (Viozan) in human plasma.

Autor: Willson VJ; Department of Drug Development Metabolism and Bioanalysis, AstraZeneca R&D Charnwood, Loughborough, Leics., UK. viv.willson@astrazeneca.com, Lockley WJ, Mather A, Singh J, Gilbert CM, Bayliss MA, Wilkinson D

Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2000 Nov; Vol. 23 (6), pp. 947-54.

A radioimmunoassay combined with solid-phase extraction for the determination (pg ml-1) of AR-C15849XX) in human plasma.

Autor: Willson VJ; Department of Physical and Metabolic Sciences, Astra Charnwood, Loughborough, UK., Preston JR, Lockley WJ, Singh J, Wilkinson D

Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 1998 Aug; Vol. 17 (4-5), pp. 793-800.

Human brain aldolase C4 isoenzyme: purification, radioimmunoassay, and distribution in human tissues.

Autor: Willson VJ, Thompson RJ

Publikováno v: Annals of clinical biochemistry [Ann Clin Biochem] 1980 May; Vol. 17 (3), pp. 114-21.

The effect of ligands on the irreversible inhibition of the NAD+-dependent isocitrate dehydrogenase from ox brain.

Autor: Willson VJ, Tipton KF

Publikováno v: European journal of biochemistry [Eur J Biochem] 1981 Jun; Vol. 117 (1), pp. 65-8.

Immunoreactive aldolase C in cerebrospinal fluid of patients with neurological disorders.

Autor: Willson VJ, Graham JG, McQueen IN, Thompson RJ

Publikováno v: Annals of clinical biochemistry [Ann Clin Biochem] 1980 May; Vol. 17 (3), pp. 110-3.